Literature DB >> 16891440

Chronic hepatitis B in hepatocarcinogenesis.

N H Park1, I H Song, Y-H Chung.   

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world, and has a wide geographical variation. Eighty per cent of HCC is attributed to hepatitis B virus (HBV). The predominant carcinogenic mechanism of HBV associated HCC is through the process of liver cirrhosis, but direct oncogenic effects of HBV may also contribute. Prevention of HBV infections as well as effective treatment of chronic hepatitis B is still needed for the global control of HBV associated HCC. Continued investigation of the mechanisms of hepatocarcinogenesis will refine our current understanding of the molecular and cellular basis for neoplastic transformation in the liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891440      PMCID: PMC2585715          DOI: 10.1136/pgmj.2006.047431

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  97 in total

1.  Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system.

Authors:  Yoshizumi Shintani; Hiroshi Yotsuyanagi; Kyoji Moriya; Hajime Fujie; Takeya Tsutsumi; Yumi Kanegae; Satoshi Kimura; Izumu Saito; Kazuhiko Koike
Journal:  J Gen Virol       Date:  1999-12       Impact factor: 3.891

Review 2.  Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

Authors:  C Bréchot; D Gozuacik; Y Murakami; P Paterlini-Bréchot
Journal:  Semin Cancer Biol       Date:  2000-06       Impact factor: 15.707

3.  AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.

Authors:  S Satoh; Y Daigo; Y Furukawa; T Kato; N Miwa; T Nishiwaki; T Kawasoe; H Ishiguro; M Fujita; T Tokino; Y Sasaki; S Imaoka; M Murata; T Shimano; Y Yamaoka; Y Nakamura
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

Review 4.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

5.  Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression.

Authors:  Ji Miao; George G Chen; Suk-Ying Chun; Paul P S Lai
Journal:  Cancer Lett       Date:  2005-06-28       Impact factor: 8.679

6.  Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.

Authors:  Y C Kim; K S Song; G Yoon; M J Nam; W S Ryu
Journal:  Oncogene       Date:  2001-01-04       Impact factor: 9.867

7.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

Authors:  M H Chang; C J Chen; M S Lai; H M Hsu; T C Wu; M S Kong; D C Liang; W Y Shau; D S Chen
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

8.  Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis.

Authors:  S W Lee; Y M Lee; S K Bae; S Murakami; Y Yun; K W Kim
Journal:  Biochem Biophys Res Commun       Date:  2000-02-16       Impact factor: 3.575

9.  Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib.

Authors:  Mitsuhiro Matsuo; Hiroaki Sakurai; Yoko Ueno; Osamu Ohtani; Ikuo Saiki
Journal:  Cancer Sci       Date:  2006-02       Impact factor: 6.716

10.  Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.

Authors:  X W Wang; M K Gibson; W Vermeulen; H Yeh; K Forrester; H W Stürzbecher; J H Hoeijmakers; C C Harris
Journal:  Cancer Res       Date:  1995-12-15       Impact factor: 12.701

View more
  18 in total

1.  Association of PTEN gene polymorphisms with liver cancer risk.

Authors:  Hong-Guang Li; Fang-Feng Liu; Hua-Qiang Zhu; Xu Zhou; Jun Lu; Hong Chang; Jin-Hua Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 2.  Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Woei-Cherng Shyu; Long-Bin Jeng; Ih-Jen Su
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

3.  In vitro anti-hepatitis B virus effect of Hypericum perforatum L.

Authors:  Ran Pang; Junyan Tao; Shuling Zhang; Jiang Zhu; Xin Yue; Lei Zhao; Pian Ye; Ying Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

4.  Biochemical Rather than Virologic Response to Interferon Therapy may be More Closely Associated with Decrease of Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis B.

Authors:  Danbi Lee; Young-Hwa Chung; Sae Hwan Lee; Yoon-Seon Lee; Don Lee; Jeong Eun Hwang; Kang Mo Kim; Young Suk Lim; Han Chu Lee; Eunsil Yu; Young Sang Lee; Dong Jin Suh
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

5.  Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro.

Authors:  Jing-yao Pang; Kui-jun Zhao; Jia-bo Wang; Zhi-jie Ma; Xiao-he Xiao
Journal:  J Zhejiang Univ Sci B       Date:  2014-06       Impact factor: 3.066

Review 6.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

Review 7.  Mouse models in liver cancer research: a review of current literature.

Authors:  Martijn W H Leenders; Maarten W Nijkamp; Inne H M Borel Rinkes
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.

Authors:  Danbi Lee; Heather Lyu; Young-Hwa Chung; Jeong A Kim; Priya Mathews; Elizabeth Jaffee; Lei Zheng; Eunsil Yu; Young Joo Lee; Soo Hyung Ryu
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

9.  HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.

Authors:  Pinbo Huang; Qiaodong Xu; Yongcong Yan; Yingjuan Lu; Zhigang Hu; Bing Ou; Heyun Zhang; Kai Mao; Jianlong Zhang; Jie Wang; Zhiyu Xiao
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

10.  Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.

Authors:  Ning Li; Yunzhu Long; Xuegong Fan; Hongbo Liu; Cui Li; Lizhang Chen; Zhiming Wang
Journal:  J Exp Clin Cancer Res       Date:  2009-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.